bpc 157 fda category 2 compounding panel votes to place popular peptide BPC-157 on list Repost @peptides with @use.repost ・・・
Repost @peptides with @use.repost BREAKING NEWS! Today's 86 advisory vote for BPC 157 is one of the biggest peptide regulatory developments we've seen in years. While nothing changes immediately, the recommendation represents Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for This just in: The FDA is proposing to move 14 commonly used peptides from Category 2 to Category 1 on the compounding review list If finalized, this shift could significantly change Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law FDA Peptide Regulation Update: Compounding Pathways and Future Directions Katherine Erickson posted on the topic LinkedIn BREAKING: The peptide landscape just changed. The FDA advisory panel voted to recommend broader pharmacy compounding access for BPC 157, KPV, and TB 500. It's one of the biggest regulatory developments the peptide space
Pay in 4 interest-free payments of $5.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
